Skip to main content

Table 2 Clinical features and severity of COVID-19 infection among symptomatic women (n = 32)

From: Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort studyAspectos clínicos e epidemiológicos da infeção pelo SARS-CoV-2 em mulheres gestantes e puérperas de Moçambique: um estudo de coorte prospectivoAspectos clínicos y epidemiológicos de la infección por SARS-CoV-2 en mujeres embarazadas y puérperas en Mozambique: un estudio de cohorte prospectivo

Clinical features and severity

Confirmed COVID-19 n = 10

Negative COVID-19 n = 22

p-value#

Number of days with symptoms before enrolment

 < 7

7 (70.0%)

14 (63.6%)

1.00

 ≥ 7

3(30.0%)

8 (36.4%)

Symptoms (Prevalence ≥ 20%)

 Cough

6 (60%)

13 (63.6%)

1.00

 Fever

4(40%)

10 (45.5%)

1.00

 Dyspnoea

7 (70%)

7 (31.8%)

0.06

 Chest pain

2 (20%)

2 (9.1%)

0.57

 Nasal congestion

3 (30%)

5 (22.7%)

1.00

 Fatigue

2 (20%)

2 (9.1%)

0.57

 Headache

2 (20%)

5 (22.7%)

1.00

 Sore throat

3 (30%)

2 (9.1%)

0.29

 Hyposmia /anosmia

5 (50%)

0 (0%)

0.00

 Ageusia

3 (30%)

0 (0%)

0.02

Initial management

 Discharge from ER

4 (40.0%)

1 (4.5%)

0.087

 Ward admission or Labour ward

5 (50.0%)

17 (77.3%)

 ICU admission

1 (10.0%)

4 (18.2%)

SARS

1 (10.5%)

3 (14.3%)

1.00

ICU admission at any time

1 (10.0%)

7 (31.8%)

0.38

  1. #Fisher’s exact test